The incompatibility of healthcare services and end-of-life needs in advanced liver disease: A qualitative interview study of patients and bereaved carers

Abstract

Background:

Liver disease represents the third commonest cause of death in adults of working age and is associated with an extensive illness burden towards the end of life. Despite this, patients rarely receive palliative care and are unlikely to be involved in advance care planning discussions. Evidence addressing how existing services meet end-of-life needs, and exploring attitudes of patients and carers towards palliative care, is lacking.

Aim:

To explore the needs of patients and carers with liver disease towards the end of life, evaluate how existing services meet need, and examine patient and carer attitudes towards palliative care.

Design:

Qualitative study – semi-structured interviews analysed using thematic analysis.

Settings/participants:

A total of 17 participants (12 patients, 5 bereaved carers) recruited from University Hospitals Bristol.

Results:

Participants described escalating physical, psychological and social needs as liver disease progressed, including disabling symptoms, emotional distress and uncertainty, addiction, financial hardship and social isolation. End-of-life needs were incompatible with the healthcare services available to address them; these were heavily centred in secondary care, focussed on disease modification at the expense of symptom control and provided limited support after curative options were exhausted. Attitudes towards palliative care were mixed, however, participants valued opportunities to express future care preferences (particularly relating to avoidance of hospital admission towards the end of life) and an increased focus on symptomatic and logistical aspects of care.

Conclusion:

The needs of patients with liver disease and their carers are frequently incompatible with the healthcare services available to them towards the end of life. Novel strategies, which recognise the life-limiting nature of liver disease explicitly and improve coordination with community services, are required if end-of-life care is to improve.

Keywords

Caregivers cirrhosis end of life health services liver disease qualitative research supportive care palliative care

Get full access to this article

View all access options for this article.

References

Williams

Aspinall

Bellis

et al . Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis. Lancet 2014; 384(9958): 1953–1997.

Effong

Osinowo

Pring

et al . Deaths from liver disease: implications for end of life care in England. Leicester: National End of Life Care Intelligence Network, 2012.

Kendrick

Getting it right: improving end of life care for people living with liver disease. London: Department of Health, 2013.

Roth

Lynn

Zhong

et al . Dying with end stage liver disease with cirrhosis: insights from SUPPORT. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. J Am Geriatr Soc 2000; 48(5 Suppl): S122–S130.

Bianchi

Marchesini

Nicolino

et al . Psychological status and depression in patients with liver cirrhosis. Digest Liver Dis 2005; 37(8): 593–600.

Vaughn-Sandler

Sherman

Aronsohn

et al . Consequences of perceived stigma among patients with cirrhosis. Digest Dis Sci 2014; 59(3): 681–686.

Poonja

Brisebois

van Zanten

et al . Patients with cirrhosis and denied liver transplants rarely receive adequate palliative care or appropriate management. Clin Gastroenterol Hepatol 2014; 12(4): 692–698.

Potosek

Curry

Buss

et al . Integration of palliative care in end-stage liver disease and liver transplantation. J Palliat Med 2014; 17(11): 1271–1277.

Walling

Wenger

NS.

Palliative care and end-stage liver disease. Clin Gastroenterol Hepatol 2014; 12(4): 699–700.

10.

Beck

Pantilat

O’Riordan

et al . Use of palliative care consultation for patients with end-stage liver disease: survey of liver transplant service providers. J Palliat Med 2016; 19(8): 836–841.

11.

Low

Vickerstaff

Davis

et al . Palliative care for cirrhosis: a UK survey of health professionals’ perceptions, current practice and future needs. Frontline Gastroenterol 2016; 7(1): 4–9.

12.

Kimbell

Murray

SA.

What is the patient experience in advanced liver disease? A scoping review of the literature. BMJ Support Palliat Care 2015; 5(5): 471–480.

13.

Kimbell

Boyd

Kendall

et al . Managing uncertainty in advanced liver disease: a qualitative, multiperspective, serial interview study. BMJ Open 2015; 5(11): e009241.

14.

Wainwright

SP.

Transcending chronic liver disease: a qualitative study. J Clin Nurs 1997; 6(1): 43–45.

15.

Lumby

Liver transplantation: the death/life paradox. Int J Nurs Pract 1997; 3(4): 231–238.

16.

Brown

Sorrell

McClaren

et al . Waiting for a liver transplant. Qual Health Res 2006; 16(1): 119–136.

17.

Arroyo

Gines

Gerbes

et al . Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 1996; 23(1): 164–176.

18.

Guardiola

Baliellas

Xiol

et al . External validation of a prognostic model for predicting survival of cirrhotic patients with refractory ascites. Am J Gastroenterol 2002; 97(9): 2374–2378.

19.

Ferenci

Lockwood

Mullen

et al . Hepatic encephalopathy – definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35(3): 716–721.

20.

Department of Health. First national VOICES survey of bereaved people – key findings report. London: Department of Health, 2012.

21.

Glaser

Strauss

Strutzel

The discovery of grounded theory: strategies for qualitative research. Nurs Res 1968; 17(4): 364.

22.

Braun

Clarke

Using thematic analysis in psychology. Qual Res Psychol 2006; 3(2): 77–101.

23.

Tong

Sainsbury

Craig

Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health C 2007; 19(6): 349–357.

24.

Orr

Homer

Ternent

et al . Health related quality of life in people with advanced chronic liver disease. J Hepatol 2014; 61(5): 1158–1165.

25.

Marchesini

Bianchi

Amodio

et al . Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology 2001; 120(1): 170–178.

26.

Van der Plas

Hansen

de Boer

et al . Generic and disease-specific health related quality of life in non-cirrhotic, cirrhotic and transplanted liver patients: a cross-sectional study. BMC Gastroenterol 2003; 3: 33.

27.

Standing

Jarvis

Orr

et al . How can primary care enhance end-of-life care for liver disease? Qualitative study of general practitioners’ perceptions and experiences. BMJ Open 2017; 7: e017106.

28.

Gomm

Farrington

End of life care in advanced kidney disease: a framework for implementation. Kidney Care National End of Life Care Programme, 3 June 2009, http://www.ncpc.org.uk/sites/default/files/EndOfLifeCareInAdvancedKidneyDisease.pdf

29.

Scottish Partnership for Palliative Care. Living and dying with advanced heart failure: a palliative care approach, http://www.palliativecarescotland.org.uk/content/publications/HF-final-document.pdf (2008, 14 accessed April 2016).

30.

Young

Hood

Woolley

et al . Report of the national audit of dementia care in general hospitals 2011: healthcare improvement quality partnership. London: Royal College of Psychiatrists, 2013.

31.

National Institute for Health and Clinical Excellence. Dementia: supporting people with dementia and their carers in health and social care. London: National Institute for Health and Clinical Excellence, 2006.

32.

Hudson

Ameneshoa

Gopfert

et al . Integration of palliative and supportive care in the management of advanced liver disease: development and evaluation of a prognostic screening tool and supportive care intervention. Frontline Gastroenterol 2017; 8: 45–52.

33.

Williams

Ashton

Aspinall

et al . Implementation of the Lancet Standing Commission on Liver Disease in the UK. Lancet 2015; 386(10008): 2098–2111.